IL17A and colitis: Bacteroides have been reported to protect against experimental colitis through the release of polysaccharide A. This anti‐inflammatory effect is mediated by a decreased production of IL‐17 in the intestine and through the promotion of CD4+ T‐cell differentiation to IL‐10‐producing Treg.86, 87